Bing Li, Debra Yu and Konstantin Poukalov, LianBio
Perceptive births its first in-house startup — and it's a China play
Perceptive Advisors is going to China.
The decision dates back two years, chief investment officer Adam Stone tells Endpoints News, when the firm began to figure out how it can, in hedge fund-speak, strategically increase its exposure to a growing biopharma market poised to be a key geographic area in the next several decades. It was a bit of a blindspot for Perceptive, he admits.
As “globalized scientist-investors, we just couldn’t afford to have that blindspot in place,” he says.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
